PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extend and enhance protection against Streptococcus pneumoniae.
Pneumococcal surface protein A (PspA) is highly immunogenic and can induce a protective immune response against pneumococcal infection. PspA is divided into two major families based on serological variability: family 1 and family 2. To provide broad protection, PspA proteins from pneumococcal strains Rx1 (family 1) and EF5668 (family 2) were combined to form two PspA fusion proteins, PspA/Rx1-EF5668 and PspA/EF5668-Rx1. Each protein was fused to a type II secretion signal and delivered by a recombinant attenuated Salmonella vaccine (RASV). Both PspA/Rx1-EF5668 and PspA/EF5668-Rx1 were synthesized in the RASV and secreted into the periplasm and supernatant. The fusion proteins reacted strongly with both anti-PspA/Rx1 and anti-PspA/EF5668 antisera. Oral immunization of BALB/c mice with RASV synthesizing either PspA fusion protein elicited serum immunoglobulin G (IgG) and mucosal IgA responses against both families of PspA. Analysis of IgG isotypes (IgG2a and IgG1) indicated a strong Th1 bias to the immune responses to both proteins. Sera from mice immunized with RASV synthesizing PspA/Rx1-EF5668 bound to the surface and directed C3 complement deposition on representative strains from all five PspA clades. Immunization with RASV synthesizing either protein protected mice against intraperitoneal challenge with Streptococcus pneumoniae WU2 strain (family 1), intravenous challenge with S. pneumoniae 3JYP2670 strain (family 2), and intranasal challenge with S. pneumoniae A66.1 (family 1). The PspA/Rx1-EF5668 protein elicited significantly greater protection than PspA/EF5668-Rx1, PspA/Rx1, or PspA/EF5668. These results indicate an RASV synthesizing a PspA fusion protein representing both PspA families constitutes an effective antipneumococcal vaccine, extending and enhancing protection against multiple strains of S. pneumoniae.
Xin
Wei
W
The Biodesign Institute, Center for Infectious Diseases and Vaccinology, Arizona State University. P.O. Box 875401, 1001 S. McAllister Ave., Tempe, AZ 85287-5401, USA. wie.xin@asu.edu
Li
Yuhua
Y
Mo
Hua
H
Roland
Kenneth L
KL
Curtiss
Roy
R
D000284:Administration, Oral; D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood; D001426:Bacterial Proteins / Q000235:genetics / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005822:Genetic Vectors; D006801:Humans; D018928:Immunity, Mucosal; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000097:blood; D051379:Mice; D008807:Mice, Inbred BALB C; D011008:Pneumococcal Infections / Q000276:immunology / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology*; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000276:immunology; D012486:Salmonella typhimurium / Q000235:genetics*; D013296:Streptococcus pneumoniae / Q000235:genetics / Q000276:immunology*; D016019:Survival Analysis
D000907:Antibodies, Bacterial; D001426:Bacterial Proteins; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D022242:Pneumococcal Vaccines; D011993:Recombinant Fusion Proteins; C051592:pneumococcal surface protein A
Infect Immun. 2007 Nov;75(11):5460-4
17698570
Adv Exp Med Biol. 1989;251:33-47
2692430
Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):593-8
19114649
Infect Immun. 2001 Apr;69(4):2154-61
11254570
J Clin Microbiol. 2003 Jan;41(1):386-92
12517877
J Med Microbiol. 2009 Jan;58(Pt 1):101-104
19074659
Infect Immun. 2000 Oct;68(10):5889-900
10992499
J Bacteriol. 1951 Sep;62(3):293-300
14888646
Infect Immun. 2004 Jan;72(1):114-22
14688088
Infect Immun. 2002 Apr;70(4):1739-49
11895935
J Clin Microbiol. 2000 Oct;38(10):3663-9
11015380
Infect Immun. 2009 May;77(5):2076-83
19255193
J Infect Dis. 2000 Dec;182(6):1694-701
11069242
Infect Immun. 1990 Oct;58(10):3293-9
1698178
J Bacteriol. 1965 Nov;90(5):1238-50
5321479
Infect Immun. 2008 Nov;76(11):5305-9
18779338
Infect Immun. 2008 Jul;76(7):3241-54
18458067
FEMS Immunol Med Microbiol. 2003 Jul 15;37(2-3):99-104
12832112
Infect Immun. 2007 Dec;75(12):5930-8
17923518
J Infect Dis. 1977 Dec;136(6):733-9
925381
Infect Immun. 1994 Dec;62(12):5683-8
7960154
Philos Trans R Soc Lond B Biol Sci. 1999 Apr 29;354(1384):777-85
10365403
Pediatr Infect Dis J. 2000 Apr;19(4):388-93
10783041
Infect Immun. 2001 Nov;69(11):6604-11
11598028
Microb Drug Resist. 1997 Winter;3(4):401-8
9442494
JAMA. 2004 Aug 11;292(6):716-20
15304469
Eur Cytokine Netw. 2003 Jul-Sep;14(3):186-91
14656695
Eur J Immunol. 1979 Apr;9(4):255-61
89033
Infect Immun. 2003 Mar;71(3):1033-41
12595413
Infect Immun. 1998 Aug;66(8):3744-51
9673257
Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4848-53
15781870
J Bacteriol. 1992 Jan;174(2):601-9
1729249
Anal Biochem. 1976 Jul;74(1):160-70
786067
Vaccine. 1996 Jun;14(9):858-67
8843627
Gene. 1990 Sep 28;94(1):29-35
2227450
Med Microbiol Immunol. 1999 May;187(4):191-8
10363675
Vaccine. 2007 Jan 22;25(6):1030-5
17084949
J Med Microbiol. 2006 Feb;55(Pt 2):215-221
16434715
Infect Immun. 2008 Nov;76(11):5238-46
18765737
Eur J Immunol. 2006 Jan;36(1):46-57
16342325
Infect Immun. 2001 Aug;69(8):4870-3
11447162
Trends Cell Biol. 2000 Dec;10(12):542-50
11121747
Vaccine. 2008 Jul 4;26(29-30):3765-71
18513840
Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16969-74
12477926
Vaccine. 1998 Jan-Feb;16(2-3):286-92
9607044
Infect Immun. 2001 Nov;69(11):6718-24
11598043
Lancet. 2000 Oct 7;356(9237):1210-1
11072934
Clin Vaccine Immunol. 2008 Mar;15(3):499-505
18184825
Infect Immun. 2007 Jan;75(1):350-7
17088353
J Infect Dis. 2005 Dec 1;192(11):1996-2003
16267773
Vaccine. 2005 May 25;23(28):3697-703
15882530
Infect Immun. 1999 Sep;67(9):4720-4
10456922
Vaccine. 2000 Dec 8;19 Suppl 1:S87-95
11163470
Eur J Clin Microbiol Infect Dis. 2007 Oct;26(10):739-42
17665229
Mol Immunol. 2003 Sep;40(2-4):95-107
12914816
J Infect Dis. 2007 Nov 15;196(10):1528-36
18008233
Infect Immun. 1999 Dec;67(12):6533-42
10569772
JAMA. 2007 Apr 25;297(16):1784-92
17456820
J Infect Dis. 1997 Apr;175(4):839-46
9086139
Clin Infect Dis. 2001 Jan;32(1):76-102
11118387
J Clin Invest. 1999 Oct;104(8):1139-47
10525053
Clin Vaccine Immunol. 2008 Oct;15(10):1529-35
18753341
J Immunol. 1979 May;122(5):1892-8
448111